版本:
中国

BRIEF-Molecular Partners regains rights to multi-DARPin drug candidate

Oct 6 Molecular Partners AG :

* Molecular Partners regains rights to multi-DARPin drug candidate targeting IL-13 & IL-17 for pulmonary indications from Janssen

* Termination of collaboration with Janssen in immunology does not impact Molecular Partners' strategy Source text for Eikon: Further company coverage: (Gdynia Newsroom)

更多 瑞士市场报道

热门文章

编辑推荐

文章推荐